Skip to content
Screener

LivaNova LIVN Common Stock

Common Stock at other companies

Abbott logo
AbbottABT
2.4B-90.5%
Haemonetics logo
HaemoneticsHAE
150M0.0%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
200M0.0%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$29K0.0%
Medtronic logo
MedtronicMDT
$0
ITG
Integer HoldingsITGR
100M0.0%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemJune 30, 2026December 31, 2025
Total Liabilities1,315,5391,406,066
Commitments and contingencies (Note 6)
Shareholders’ Equity:
Ordinary Shares, £1.00 par value: Unlimited shares authorized; 55,601,145 shares issued and 55,051,768 shares outstanding as of June 30, 2026; 55,535,181 shares issued and 54,649,085 shares outstanding as of December 31, 202584,59984,564
Additional paid-in capital2,270,6992,254,980
Accumulated other comprehensive (loss) income(14,386)7,330
Accumulated deficit(1,014,858)(1,145,721)
Treasury shares at cost, 549,377 ordinary shares as of June 30, 2026; 886,096 ordinary shares as of December 31, 2025(732)(1,166)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's common stock?
LivaNova (LIVN) reported common stock of $84.6M in Q2 2026.
How has LivaNova's common stock changed year-over-year?
LivaNova's common stock increased by 0.1% year-over-year, from $84.52M to $84.6M.
What is the long-term trend for LivaNova's common stock?
Over 5 years (2020 to 2025), LivaNova's common stock has grown at a 2.1% compound annual growth rate (CAGR), from $76.3M to $84.56M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about LivaNova's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude